Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Lancet Diabet Endocrinol 11:3341
Improper storage of GLP-1 medications can compromise their therapeutic effectiveness and safety
Muscle Pain and Tirzepatide Zepbound Zepbound Does Zepbound Cause Shortness of Breath
In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
Unexplained weight loss that feels too rapid
